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Introduction
Juvenile Dermatomyositis (JDM) is the most common
idiopathic inflammatory myopathy in childhood, a sys-
temic vasculopathy that usually affects skin and skeletal
muscle but also can affect gastrointestinal tract and other
organs. Diagnosis is based on Bohan and Peter’s criteria
and the goals of treatment include control of skin and
muscle symptoms and prevention of disease complica-
tions. Stepwise aggressive treatment decreases JDM activ-
ity and improves long-term outcome.
Muscle involvement in JDM can be assessed by electro-
myography (EMG), magnetic resonance imaging (MRI)
and/or muscle biopsy.
Muscle biopsy assesses the presence of lymphocytic
inflammatory infiltrate, perifascicular atrophy, muscle
fibers necrosis and it allows studying the overexpression of
major histocompatibility complex (MHC) class I in the
sarcolemma and sarcoplasm of the muscle cell. In healthy
muscles, there is no MHC class I expression but in inflam-
matory myopathies there is a distinctive and generalized
overexpression, not limited to the affected areas, it appears
before the inflammatory infiltrate occurs and it is not
modified by immunosuppressive treatment.
Objectives
To assess MHC I overexpression on muscle biopsy of our
patients with JDM.
Methods
Descriptive retrospective review of our JDM patients with
muscle biopsy at diagnosis between January 2000 and
December 2011. In all cases, muscle biopsy techniques
were performed with hematoxylin-eosin, trichrome, oxi-
dative enzymes (NADH, SDH, COX and COX-SDH),
neonatal myosin and MHC class I.
Results
12 patients were included, 8 of them were girls (66%). All
children had cutaneous and muscular clinical features at
diagnosis. All MRI were pathological before treatment.
EMG was performed in 9 patients, being altered in 8
of them (88%). Childhood Myositis Assessment Scale
(CMAS) was done in 6 children with a median score of
30.5/52 (range 12-50/52). We found pathological muscle
biopsy in 8 children (66%). Mild endomisial inflammation
was found in 5 (41%) patients and moderate inflammation
in 4 (33%). No vasculitis was found, but 7 (58%) patients
had necrotic muscle fibers in biopsy. Immunohistochem-
ical staining for MHC class I was positive in all cases, even
in those children with normal muscle biopsy.
Conclusion
MHC class I overexpression is present in muscle biopsy of
all our patients with suspected JDM, even those with nega-
tive EMG or normal CMAS score. Although it is an inva-
sive technique, muscle biopsy including MHC class I
staining should be performed in all patients with suspected
JDM in order to achieve more accurate diagnostic and
establish an early and aggressive treatment.
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